- collapse A Single-centre, Double-blind, Double-dummy, Randomised, Placebo Controlled, Four-period Crossover Study in Healthy Male Volunteers, to Assess the Effect on QT/QTc Interval of Single Oral Doses of AZD1981 (200 mg and 2000 mg) Using Moxifloxacin (Avelox®) as a Positive Control
- collapse A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa
- collapse Protection of Ovarian Function with Goserelin Acetate in Premenopausal Early Breast Cancer Patients Undergoing Adjuvant Chemotherapy: An Open Label, Randomised, Multi-Centre, Phase IIIb Study
- collapse An Open Label, 4-Week, Randomised, Multi-Centre, Phase IV Study to Compare the Efficacy and Safety of Quetiapine Fumarate (SeroquelTM) as Mono-Therapy or adjunct to lithium in the Treatment of Patients with Acute Mania in Bipolar Disorder
- collapse A Multicenter, Rand., Double-blind, Parallel-group, Pbo-controlled Study of the Efficacy and Safety of SEROQUEL XR Compared with Pbo as an Adjunct to Treatment in Patients with Generalized Anxiety Disorder who Demonstrate Partial or No Response to a SSRI or SNRI Alone or in Combination with a Benzo.
- collapse A Double Blind Randomized Trial of Cediranib versus placebo in patients receiving Paclitaxel/Carboplatin Chemotherapy for the treatment of Advanced or Metastatic Non-Small Cell Lung Cancer
- collapse A randomised placebo-controlled trial of concurrent cediranib [ZD2171] (with platinum-based chemotherapy) and concurrent and maintenance cediranib in women with platinum-sensitive relapsed ovarian cancer.
- collapse This group of 20 plus NCI studies does not have a protocol title.
- collapse Phase 1, Open-Label, Dose-Seeking Study of AZD2171 given daily orally in combination with standard chemotherapy regimens in patients with advanced incurable non-small cell lung cancer or colorectal cancer
